73
Participants
Start Date
September 10, 2021
Primary Completion Date
May 31, 2026
Study Completion Date
May 31, 2026
Selinexor
oral drug that comes in 20 mg tablets
Dexamethasone Oral
Dexamethasone 40 mg on Days 1, 8, 15, 22 of each cycle. However, those \>75 years old may be administered a weekly dose of 20 mg dexamethasone.
Daratumumab
"Patients will receive daratumumab subcutaneously (SC, or under the skin) as an injection. The recommended dosage of the SC formulation is 1,800 mg daratumumab and 30,000 units hyaluronidase administered SC into the abdomen over approximately 3 to 5 minutes according to recommended schedule.~Daratumumab 1800 mg subcutaneously once weekly in Cycles 1 and 2, every 2 weeks in cycles 3 to 6, and every 4 weeks thereafter."
Lenalidomide
Patients will receive a 21-day supply of lenalidomide (15 mg) as oral capsules, as appropriate, for each 28-day treatment cycle
New York Oncology Hematology, P.C., Albany
Virginia Cancer Specialists, PC, Gainesville
Maryland Oncology Hematology, P.A., Columbia
Texas Oncology, P.A., Tyler
Texas Oncology, P.A., Fort Worth
Texas Oncology, P.A., San Antonio
Texas Oncology, P.A., Austin
Rocky Mountain Cancer Centers, Denver
Arizona Oncology Associates, PC - HOPE, Tucson
Willamette Valley Cancer Institute and Research Center, Eugene
Collaborators (1)
Karyopharm Therapeutics Inc
INDUSTRY
US Oncology Research
INDUSTRY